JPH06239734A - Preparation of liposome and loposome formulation - Google Patents

Preparation of liposome and loposome formulation

Info

Publication number
JPH06239734A
JPH06239734A JP5473893A JP5473893A JPH06239734A JP H06239734 A JPH06239734 A JP H06239734A JP 5473893 A JP5473893 A JP 5473893A JP 5473893 A JP5473893 A JP 5473893A JP H06239734 A JPH06239734 A JP H06239734A
Authority
JP
Japan
Prior art keywords
solution
liposome
ethanol
lipid
aqueous solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5473893A
Other languages
Japanese (ja)
Inventor
Yasushi Sumida
康史 炭田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanebo Ltd
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Priority to JP5473893A priority Critical patent/JPH06239734A/en
Publication of JPH06239734A publication Critical patent/JPH06239734A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)

Abstract

PURPOSE:To make it possible to simply prepare uniform liposome having small particle diameter in large amount. CONSTITUTION:This method for preparing liposome formulation is characterized by preparing liposome by dissolving a lipid in ethanol or an ethanol aqueous solution and adding the solution to an aqueous solution or adding the aqueous solution to the lipid solution. The liposome formulation is prepared by the method.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、医薬品、医薬部外品、
化粧品等に適用されるリポソームの製造方法及びリポソ
ーム製剤に関する。さらに詳しくは、脂質をエタノール
に溶解し、該溶液を水性溶液に添加するか、あるいは該
溶液に水性溶液を添加してリポソームを調製することに
より簡易かつ大量に調製することを可能ならしめる調製
方法及び該方法により調製したリポソーム製剤に関す
る。
BACKGROUND OF THE INVENTION The present invention relates to pharmaceuticals, quasi drugs,
The present invention relates to a method for producing liposomes applied to cosmetics and the like, and a liposome preparation. More specifically, a preparation method which enables simple and large-scale preparation by dissolving a lipid in ethanol and adding the solution to an aqueous solution, or by adding an aqueous solution to the solution to prepare liposomes. And a liposome preparation prepared by the method.

【0002】[0002]

【従来の技術及び発明が解決しようとする課題】リポソ
ームは脂質2分子膜からなる閉鎖小胞体である。天然の
生体膜は、脂質の2分子膜構造をとっているといわれて
おり、このリポソームは生体膜類似の構造をとっている
ことから細胞膜との高い親和性を有し、ドラッグキャリ
ヤーとしての高いポテンシャルが期待されている。近
年、DDSを目指したリポソーム製剤の開発は医薬品分
野だけでなく化粧品分野においてもますます盛んであ
る。
BACKGROUND OF THE INVENTION Liposomes are closed vesicles composed of a lipid bilayer. Natural biological membranes are said to have a bilayer membrane structure of lipids, and since this liposome has a structure similar to that of biological membranes, it has a high affinity for cell membranes and is a high drug carrier. Potential is expected. In recent years, the development of liposome preparations aiming at DDS has become more and more active not only in the pharmaceutical field but also in the cosmetic field.

【0003】しかしながら、商品としての大量生産を考
えた場合に従来のリポソームの調製方法は非常に困難な
ものばかりであり、実用的ではない。例えば、以下の方
法が代表的なものとしてあげられる。
However, when considering mass production as a commercial product, conventional methods for preparing liposomes are very difficult and not practical. For example, the following methods are typical.

【0004】(1)脂質を適当な有機溶媒(たとえば、
クロロホルム、エーテル等)に溶解させ、減圧下にこれ
らの溶媒を留去し、一旦脂質薄膜を形成させた後、該脂
質薄膜を機械的撹拌手段により水に水和(あるいは膨
潤)させる方法。
(1) The lipid is added to a suitable organic solvent (for example,
Chloroform, ether, etc.), these solvents are distilled off under reduced pressure to once form a lipid thin film, and then the lipid thin film is hydrated (or swollen) in water by a mechanical stirring means.

【0005】(2)脂質をエーテルあるいはエタノール
等の有機溶媒に溶解させ、この溶液を高温に暖めた水中
にシリンジあるいはノズル等より、加圧下、一定速度で
注入し、注入とともに有機溶媒が留去あるいは希釈され
ることにより脂質が二重層を形成し、リポソームが調製
される方法。
(2) A lipid is dissolved in an organic solvent such as ether or ethanol, and the solution is injected into water warmed to a high temperature at a constant rate under pressure from a syringe or a nozzle, and the organic solvent is distilled off along with the injection. Alternatively, a method in which a lipid forms a bilayer by being diluted to prepare a liposome.

【0006】(3)脂質をコール酸あるいはデオキシコ
ール酸などの界面活性剤とともに水溶液中で混合ミセル
を形成させ、該ミセル溶液を透析あるいはゲル濾過等の
操作によりコール酸あるいはデオキシコール酸などの界
面活性剤を除去し、リポソームを調製する方法。
(3) Lipids are mixed with a surfactant such as cholic acid or deoxycholic acid in an aqueous solution to form mixed micelles, and the micelle solution is subjected to an operation such as dialysis or gel filtration to obtain an interface of cholic acid or deoxycholic acid. A method for preparing a liposome by removing an active agent.

【0007】(4)脂質を溶解した有機溶媒を水相に加
え、超音波処理し、一旦W/O型エマルションを形成
し、ついで有機溶媒を除去することによりゲル化させ、
このゲルを機械的撹拌により転相させリポソームを調製
する方法。
(4) A lipid-dissolved organic solvent is added to the aqueous phase and ultrasonicated to once form a W / O type emulsion, and then the organic solvent is removed to form a gel,
A method for preparing liposomes by subjecting this gel to phase inversion by mechanical stirring.

【0008】上記調製法のうち(1)の調製法ではクロ
ロホルム、エーテル等の揮発性の有機溶媒を用いてお
り、工業的にはこれらの溶媒を用いることは好ましくな
い。また減圧下にこれらの溶媒を留去することも簡便性
を考慮すれば好ましくない。(2)の調製法ではシリン
ジ、ノズル等によって注入するため製造速度が非常に遅
くなる。(3)の調製法では透析、ゲル濾過等の操作が
あるため簡便ではない。(4)の調製法でも有機溶媒の
除去という操作があり簡便ではない。
In the preparation method (1) of the above preparation methods, volatile organic solvents such as chloroform and ether are used, and it is not preferable to use these solvents industrially. Further, it is not preferable to distill off these solvents under reduced pressure in view of simplicity. In the preparation method (2), the injection speed is extremely slow because it is injected by a syringe, a nozzle, or the like. The preparation method (3) is not simple because it involves operations such as dialysis and gel filtration. The preparation method of (4) also involves an operation of removing the organic solvent and is not simple.

【0009】[0009]

【課題を解決するための手段】そこで本発明者は、これ
らの問題点を解決すべく鋭意検討を加え、その結果、脂
質をエタノールに溶解し、該溶液を水に添加するか、あ
るいは該溶液に水を添加するという極めて簡便な方法で
リポソームが調製し得ることを新規に見いだし、本発明
を完成させたのである。
Therefore, the present inventors have made diligent studies to solve these problems, and as a result, the lipid is dissolved in ethanol and the solution is added to water, or the solution is added. The inventors have newly found that liposomes can be prepared by an extremely simple method of adding water to the present invention, and completed the present invention.

【0010】上記の本発明にあっては、特に超音波照射
器、高圧乳化機あるいは特殊なノズル等の設備上、操作
技術上の何等の工夫も必要とせず、単に撹拌するだけで
粒子径の小さい均一なリポソームが調製し得る点に特徴
を有するものである。
In the present invention described above, there is no need for any special technique in terms of equipment such as an ultrasonic irradiator, a high-pressure emulsifier, a special nozzle, or the like, and an operation technique. It is characterized in that small uniform liposomes can be prepared.

【0011】以下、本発明の構成の詳細について説明す
る。本発明で用いられる脂質は、例えばホスファチジル
コリン、ホスファチジルエタノールアミン、ホスファチ
ジルセリン、ホスファチジルイノシトール、リゾホスフ
ァチジルコリン、スフィンゴミエリン、卵黄レシチン、
大豆レシチン、水添卵黄レシチン、水添大豆レシチン等
に代表されるリン脂質の他、糖脂質、ジアルキル、トリ
アルキル型合成界面活性剤等の一種又は二種以上の混合
物が主体となる。なお、これらに膜安定化剤としてコレ
ステロール、コレスタノール等のステロール類を荷電物
質としてジセチルホスフェート、ホスファチジン酸、ガ
ングリオシド、ステアリルアミン等を、さらに酸化防止
剤としてα−トコフェロール等を加えても良い。
The details of the configuration of the present invention will be described below. Lipids used in the present invention, for example, phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylinositol, lysophosphatidylcholine, sphingomyelin, egg yolk lecithin,
In addition to phospholipids typified by soybean lecithin, hydrogenated egg yolk lecithin, hydrogenated soybean lecithin, etc., one or a mixture of two or more glycolipids, dialkyl, trialkyl type synthetic surfactants and the like is mainly used. It should be noted that sterols such as cholesterol and cholestanol may be added to these as film stabilizers, and dicetyl phosphate, phosphatidic acid, ganglioside, stearylamine and the like as charged substances, and α-tocopherol and the like as an antioxidant.

【0012】本発明で用いられるエタノールは一般に医
薬品、化粧品原料として用いられるもので、エタノール
水溶液のエタノール濃度は50〜100重量%が好まし
い。エタノール濃度が50重量%以下になると脂質が溶
解しなくなるので好ましくない。また、エタノールある
いはエタノール水溶液の使用量は脂質に対し、約1〜1
00重量倍が好ましい。使用量が1重量倍以下になると
脂質が溶解しなくなるので好ましくなく、100重量倍
を超えてもその増加分に見合った溶解性の向上は望めな
いものである。油溶性成分あるいは油溶性薬剤を添加す
る場合には脂質とともにこのエタノールあるいはエタノ
ール水溶液に溶解すればよい。
The ethanol used in the present invention is generally used as a raw material for medicines and cosmetics, and the ethanol concentration of the aqueous ethanol solution is preferably 50 to 100% by weight. When the ethanol concentration is 50% by weight or less, lipids are not dissolved, which is not preferable. The amount of ethanol or ethanol aqueous solution used is about 1 to 1 with respect to the lipid.
It is preferably 100 times by weight. If the amount used is less than 1 times by weight, the lipid will not be dissolved, which is not preferable, and even if it exceeds 100 times by weight, improvement in solubility commensurate with the increase cannot be expected. When an oil-soluble component or an oil-soluble drug is added, it may be dissolved in this ethanol or ethanol aqueous solution together with the lipid.

【0013】該溶液に添加あるいは該溶液を添加する水
性溶液としては水、生理食塩水、緩衝溶液、糖液、その
他水溶性成分あるいは水溶性薬剤の水溶液が使用され
る。
As the aqueous solution to be added to the solution or to add the solution, water, physiological saline, buffer solution, sugar solution, or other aqueous solution of water-soluble component or water-soluble drug is used.

【0014】調製方法としては、例えば次のように行
う。まずエタノールあるいはエタノール水溶液に脂質、
膜安定化剤、油溶性成分等を加え、加温、撹拌して均一
に溶解させる。このときの温度は50〜80℃が好まし
い。これは脂質の相転移温度以上の温度であり、脂質が
溶解しやすい。これとは別に水溶性成分等を溶解した水
性溶液を50〜80℃に加温しておき、先のエタノール
溶液に添加するかあるいはエタノール溶液を水性溶液に
添加し、撹拌する。このようにして粒子径の小さい均一
なリポソームが調製され得る。
The preparation method is, for example, as follows. First of all, lipid in ethanol or ethanol aqueous solution,
A film stabilizer, an oil-soluble component, etc. are added, and heated and stirred to dissolve uniformly. The temperature at this time is preferably 50 to 80 ° C. This is a temperature above the phase transition temperature of the lipid, and the lipid is easily dissolved. Separately from this, an aqueous solution in which a water-soluble component or the like is dissolved is heated to 50 to 80 ° C. and then added to the above ethanol solution or the ethanol solution is added to the aqueous solution and stirred. In this way, uniform liposomes having a small particle size can be prepared.

【0015】本発明のリポソームには、例えば一般的に
汎用される製剤構成成分として水溶性高分子、多価アル
コール、防腐剤、キレート剤等が添加され得る。
To the liposome of the present invention, for example, a water-soluble polymer, a polyhydric alcohol, an antiseptic, a chelating agent, etc. can be added as a generally used formulation constituent.

【0016】[0016]

【実施例】以下、実施例について説明する。尚、実施例
に示すwt%は、重量%を意味する。
EXAMPLES Examples will be described below. In addition, wt% shown in the examples means% by weight.

【0017】実施例1 エタノール10gを50℃に加温し、水添精製大豆レシ
チン1.0g、コレステロール0.5g、α−トコフェ
ロール0.1gを加えて撹拌し、均一に混合溶解した。
これとは別に、水88.4gを60℃に加熱しておき、
これを先のエタノール溶液に添加、撹拌した。乳白色の
リポソーム溶液が得られ、平均粒子径は120nmであ
った。また電子顕微鏡観察(TEM)ではリポソームに
特徴的なラメラ構造が確認でき、また均一な粒子を形成
していることが確認できた。
Example 1 10 g of ethanol was heated to 50 ° C., 1.0 g of hydrogenated purified soybean lecithin, 0.5 g of cholesterol and 0.1 g of α-tocopherol were added and stirred to uniformly mix and dissolve them.
Separately, 88.4 g of water was heated to 60 ° C.,
This was added to the above ethanol solution and stirred. A milky white liposome solution was obtained, and the average particle size was 120 nm. In addition, electron microscopic observation (TEM) confirmed the characteristic lamellar structure of the liposome, and confirmed that uniform particles were formed.

【0018】実施例2 実施例1において、水の代わりにカルボキシフルオレセ
イン(CF)100mM水溶液を用い、調製した。この
リポソーム溶液をゲル濾過し、外相のCFを取り除いた
後、TritonX−100水溶液を添加前後の蛍光強
度を測定することにより、内相にCFがトラップされて
いることが確認できた。尚、保持効率は8.5%であっ
た。
Example 2 In Example 1, a 100 mM aqueous solution of carboxyfluorescein (CF) was used in place of water to prepare water. It was confirmed that CF was trapped in the inner phase by gel filtration of this liposome solution to remove CF in the outer phase and then measuring the fluorescence intensity before and after the addition of the Triton X-100 aqueous solution. The retention efficiency was 8.5%.

【0019】以上、実施例1、2より本発明の調製法に
よってリポソームが調製可能であることは明かである。
From the above, it is clear from Examples 1 and 2 that liposomes can be prepared by the preparation method of the present invention.

【0020】実施例3 30%エタノール水溶液20gを65℃に加温し、水添
精製卵黄レシチン2.5g、コレステロール1.0g、
ジセチルホスフェート0.5gを加えて撹拌し、均一に
混合溶解した。これとは別に、アスコルビン酸リン酸マ
グネシウム3.0g、水73gを60℃に加熱、均一溶
解した。この水溶液に先のエタノール溶液を添加、撹拌
し、乳白色のリポソーム溶液を得た。平均粒径100n
m、保持効率19.5%であった。TEMにて均一なリ
ポソームを確認した。
Example 3 20 g of a 30% aqueous ethanol solution was heated to 65 ° C., 2.5 g of hydrogenated and purified egg yolk lecithin, 1.0 g of cholesterol,
0.5 g of dicetyl phosphate was added and stirred to uniformly mix and dissolve. Separately, 3.0 g of magnesium ascorbyl phosphate and 73 g of water were heated to 60 ° C. and uniformly dissolved. The above ethanol solution was added to this aqueous solution and stirred to obtain a milky white liposome solution. Average particle size 100n
m, retention efficiency was 19.5%. A uniform liposome was confirmed by TEM.

【0021】実施例4 20%エタノール水溶液20kgを60℃に加温し、水
添精製大豆レシチン1.5kg、コレステロール0.5
kg、α−トコフェロール0.1kgを加えて撹拌し、
均一に混合溶解した。これとは別に、水77.9kgを
60℃に加熱しておき、これを先のエタノール溶液に添
加、撹拌した。乳白色のリポソーム溶液が得られ、平均
粒径120nm、TEMにて均一なリポソームを確認し
た。
Example 4 20 kg of 20% aqueous ethanol solution was heated to 60 ° C., 1.5 kg of hydrogenated and purified soybean lecithin, and 0.5 kg of cholesterol.
kg, 0.1 kg of α-tocopherol, and stirred,
It was mixed and dissolved uniformly. Separately, 77.9 kg of water was heated to 60 ° C., and this was added to the above ethanol solution and stirred. A milky white liposome solution was obtained, and uniform liposomes were confirmed by TEM with an average particle size of 120 nm.

【0022】実施例5 実施例4における水にグルコース0.1kgを溶解し、
調製した。ゲル濾過し、保持効率を求めたところ、1
2.6%であった。
Example 5 0.1 kg of glucose was dissolved in water in Example 4,
Prepared. After gel filtration, the retention efficiency was calculated to be 1
It was 2.6%.

【0023】[0023]

【発明の効果】以上述べた通り、本発明によれば、これ
までの方法と異なり非常に簡便な方法で、また非常に大
量にリポソームを調製し得るとともに、粒子径の小さい
均一なリポソームを調製し得ることが明かである。
As described above, according to the present invention, unlike the conventional methods, it is possible to prepare a liposome in a very simple manner and in a very large amount, and to prepare a uniform liposome having a small particle size. It is clear that you can do it.

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 脂質をエタノールあるいはエタノール水
溶液に溶解し、該溶液を水性溶液に添加するか、あるい
は該溶液に水性溶液を添加してリポソームを調製するこ
とを特徴とするリポソームの調製方法。
1. A method for preparing liposomes, which comprises dissolving a lipid in ethanol or an ethanol aqueous solution and adding the solution to an aqueous solution, or adding an aqueous solution to the solution to prepare a liposome.
【請求項2】 請求項1記載の方法によって調製してな
るリポソーム製剤。
2. A liposome preparation prepared by the method according to claim 1.
JP5473893A 1993-02-18 1993-02-18 Preparation of liposome and loposome formulation Pending JPH06239734A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP5473893A JPH06239734A (en) 1993-02-18 1993-02-18 Preparation of liposome and loposome formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5473893A JPH06239734A (en) 1993-02-18 1993-02-18 Preparation of liposome and loposome formulation

Publications (1)

Publication Number Publication Date
JPH06239734A true JPH06239734A (en) 1994-08-30

Family

ID=12979132

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5473893A Pending JPH06239734A (en) 1993-02-18 1993-02-18 Preparation of liposome and loposome formulation

Country Status (1)

Country Link
JP (1) JPH06239734A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998033482A1 (en) * 1997-02-04 1998-08-06 Abbott Laboratories Pain reducing parenteral liposome formulation
WO2000072824A1 (en) * 1999-06-01 2000-12-07 Ono Pharmaceutical Co., Ltd. Microliposomes and process for producing the same
JP2001278811A (en) * 2000-03-29 2001-10-10 Nonogawa Shoji Kk Skin care preparation
WO2012133121A1 (en) * 2011-03-25 2012-10-04 テルモ株式会社 Long-lasting controlled-release liposome composition and method for producing same
JP2013539402A (en) * 2010-06-23 2013-10-24 ブライトサイド イノベーションズ,インコーポレイティド Lecithin carrier vesicles and method for producing the same
JP2013255912A (en) * 2012-05-15 2013-12-26 Chiba Univ Liposome and method of making the same
US9724300B2 (en) 2012-09-21 2017-08-08 Terumo Kabushiki Kaisha Long-lasting, controlled-release local anesthetic liposome preparation

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998033482A1 (en) * 1997-02-04 1998-08-06 Abbott Laboratories Pain reducing parenteral liposome formulation
WO2000072824A1 (en) * 1999-06-01 2000-12-07 Ono Pharmaceutical Co., Ltd. Microliposomes and process for producing the same
JP2001278811A (en) * 2000-03-29 2001-10-10 Nonogawa Shoji Kk Skin care preparation
JP4558132B2 (en) * 2000-03-29 2010-10-06 日本メナード化粧品株式会社 Skin preparation
JP2013539402A (en) * 2010-06-23 2013-10-24 ブライトサイド イノベーションズ,インコーポレイティド Lecithin carrier vesicles and method for producing the same
WO2012133121A1 (en) * 2011-03-25 2012-10-04 テルモ株式会社 Long-lasting controlled-release liposome composition and method for producing same
JP5889279B2 (en) * 2011-03-25 2016-03-22 テルモ株式会社 Sustained sustained release liposome composition and production method thereof
US9877918B2 (en) 2011-03-25 2018-01-30 Terumo Kabushiki Kaisha Long-lasting controlled-release liposome composition and method for producing same
JP2013255912A (en) * 2012-05-15 2013-12-26 Chiba Univ Liposome and method of making the same
US9724300B2 (en) 2012-09-21 2017-08-08 Terumo Kabushiki Kaisha Long-lasting, controlled-release local anesthetic liposome preparation

Similar Documents

Publication Publication Date Title
US4687661A (en) Method for producing liposomes
KR0157428B1 (en) Lipid excipient for nasal delivery and topical application
US5021200A (en) Process for the production of aqueous dispersions of lipid spheres
US4394372A (en) Process for making lipid membrane structures
Lesoin et al. CO2/water/surfactant ternary systems and liposome formation using supercritical CO2: a review
JPS607934A (en) Preparation of liposome
JPS63501278A (en) A method for forming lipid spherules dispersed in an aqueous phase easily and with high stability and degree of encapsulation.
DD201973A5 (en) PROCESS FOR THE PREPARATION OF LIPOSOMAL MEDICAMENTS
Tarekegn et al. Niosomes in targeted drug delivery: some recent advances
JP2006131567A (en) Method for producing liposome suspension and application using liposome
ITMI942142A1 (en) KETOPROFEN LIPOSOMES
EP0551169A1 (en) Liposome composition and production thereof
WO2016108634A2 (en) Hybrid-type multi-lamellar nanostructure of epidermal growth factor and liposome and method for manufacturing same
JPH06239734A (en) Preparation of liposome and loposome formulation
JP3187622B2 (en) Liposome
KR100768151B1 (en) Nanoliposome using esterified lecithin
CA2089494C (en) Vesicles in non-polar media
JPH0436735B2 (en)
JP4669665B2 (en) Polycation-modified liposome having no cytotoxicity and method for producing the same
DE3802357A1 (en) PARENTERAL SUSPENSIONS
RU2605616C1 (en) Liposomal agent based on ubiquinol and preparation method thereof
CN104056285A (en) Preparation method of emulsion for magnetic resonance imaging of lung
JP3831958B2 (en) Lipid mixed lipid and liposome dispersion
JPH0437731B2 (en)
RU2448731C2 (en) Phospholipid composition